Sanius Health has announced a deal valued at £225 million which will see its data, research and personalised health patient AI platform leveraged by primary care provider Modality Partnership through a 10-year collaboration.

Sanius Health has announced a deal valued at £225 million which will see its data, research and personalised health patient AI platform leveraged by primary care provider Modality Partnership through a 10-year collaboration.

The deal will see Modality Partnership utilising Sanius Health’s AI and clinical services, offering “enhanced coaching and clinical support”, with the potential to benefit over 500,000 patients across the UK. The platform is described as an AI-powered digital data bank and patient ecosystem, combining medical records, wearable tech, DNA kits, quality-of-life data and socioeconomic information to support care, outcomes and research.

To date, Sanius Health describes reported benefits of the platform including 52 percent reduction in emergency department admissions, 50 percent improvement in length-of-stay and £16 million in cost savings within a single disease area.

The new deal follows work between Sanius Health and Modality Partnership in respiratory medicine, with Modality Partnership’s group clinical chair Dr Mina Gupta noting that it is seen “as a natural next step in our journey together.”

Sanius Health’s founder and CEO Orlando Agrippa comments: “It’s been a pleasure to work with the entire Modality family, and we look forward to 10 amazing years. We are ultra-passionate about improving outcomes for patients while accelerating access to novel data and personalised medicine technologies for clinical colleagues in research and supporting industry partners to improve evidence generation for drug approvals.”

Vincent Sai, group CEO and partner of Modality Partnership, also expressed enthusiasm, noting that he is “delighted to be partnering with Sanius to help patients living with life changing conditions.”